Skip Nav Destination
About the Journal
Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also publishes News and Research Watch sections.Read More About the Journal
Impact Factor
38.272
Featured Articles
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
Noted This Week
JUUL Labs must stop selling and distributing all its electronic cigarette (e-cigarette) devices and pods, which are filled with nicotine-containing liquid that is vaporized and inhaled by users, and products currently on the market must be removed from store shelves, the FDA ordered. The agency said that the company’s applications to sell the products "lacked sufficient evidence…that marketing of the products would be appropriate for the protection of the public health." The FDA has said that e-cigarette use has dramatic increased among youth, but the company, which plans to appeal the decision, has advertised its e-cigarettes as a tool to help current smokers quit using traditional combustible cigarettes.
Trending - Altmetric
Ruxolitinib with Navitoclax Is Efficacious and Safe in Myelofibrosis
Last mentioned on Wednesday June 29 2022
Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence
Last mentioned on Thursday June 30 2022
Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors
Last mentioned on Tuesday June 28 2022
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
Last mentioned on Wednesday June 29 2022
Human colon cancer-derived Clostridioides difficile strains drive colonic tumorigenesis in mice
Last mentioned on Wednesday June 29 2022
Advertisement